Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.
about
Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trialsSalmonella as a vaccine delivery vehicleGene therapy in pancreatic cancer.Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.Trial watch: Naked and vectored DNA-based anticancer vaccinesCurrent status and future directions of anti-angiogenic therapy for gliomasTrial watch: DNA vaccines for cancer therapy.Live-attenuated bacteria as a cancer vaccine vector.Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer.Intracellular delivery of biologic therapeutics by bacterial secretion systems.Trial Watch: DNA vaccines for cancer therapy.A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated
P2860
Q26781538-3CDAA8F7-D527-4408-8347-881BA16374D5Q27011946-6E9F2936-82F4-4715-9996-809B8A1C693CQ34302954-ED139611-3F0C-406C-A838-452BEE1C41D8Q35798947-034DCAE7-95BE-45F5-9DC6-933011AD7A16Q35798986-B0444393-7531-47AD-B8F2-20A8EC952394Q36618235-6C99FC63-C085-4425-9627-2A36049AE0C6Q36845824-89C06849-0B77-433F-BAAD-F08853A16D46Q38152473-73BF705A-DD3F-4E40-A28A-DF750D7A976BQ38165930-48BE6021-AD9A-494F-A313-35D6609E8114Q38734240-C55C4EA2-7AF3-413F-BDDD-8DA959CBF34EQ42552005-5D423900-9606-4BDB-9F0B-350BB371110AQ52597561-7D318BB8-4F80-47FD-86EB-5871FD9112F9Q57300412-FD9ED573-8362-445A-8954-92C57C6D2646
P2860
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@ast
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@en
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@nl
type
label
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@ast
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@en
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@nl
prefLabel
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@ast
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@en
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Double-blind, placebo-controll ...... ly advanced pancreatic cancer.
@en
P2093
Andreas G Niethammer
Christine Leowardi
Friedrich H Schmitz-Winnenthal
Heinz Lubenau
Lars Grenacher
Marco Springer
Markus W Buchler
Moritz Koch
Mustafa Akhisaroglu
Nicolas Hohmann
P2860
P2888
P356
10.1186/1471-2407-12-361
P407
P577
2012-08-20T00:00:00Z
P5875
P6179
1044632467